Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44M Sell
182,624
-566,945
-76% -$10.6M 0.02% 509
2025
Q4
$11.7M Buy
+749,569
New +$11.1M 0.04% 314
2025
Q3
Sell
-318,066
Closed -$3.95M 1052
2025
Q2
$3.95M Buy
318,066
+307,086
+2,797% +$3.87M 0.02% 356
2025
Q1
$167K Buy
+10,980
New +$164K ﹤0.01% 655
2021
Q2
Sell
-20,705
Closed -$284K 750
2021
Q1
$284K Buy
+20,705
New +$300K ﹤0.01% 419
2015
Q3
Sell
-56,065
Closed -$2.71M 477
2015
Q2
$2.71M Buy
56,065
+42,400
+310% +$2.18M 0.03% 171
2015
Q1
$683K Sell
13,665
-41,443
-75% -$2.25M 0.01% 232
2014
Q4
$3.61M Sell
55,108
-38,195
-41% -$2.66M 0.03% 146
2014
Q3
$7.1M Buy
93,303
+74,086
+386% +$6.13M 0.06% 71
2014
Q2
$1.58M Sell
19,217
-46,011
-71% -$3.43M 0.01% 205
2014
Q1
$4.58M Buy
65,228
+43,695
+203% +$3M 0.04% 109
2013
Q4
$1.54M Buy
+21,533
New +$1.57M 0.01% 182

Other funds holding NOV

Bridgewater Associates's NOV Position: Q1 2026 in Review

Bridgewater Associates reduced its NOV (NOV) stake by 76% in Q1 2026, selling an estimated $10.6M and leaving 182,624 shares worth $3.44M. The position accounts for 0.02% of the portfolio, ranked #509.

Bridgewater Associates first reported a position in NOV in Q4 2013 and has held it in 12 quarters since. The position peaked at $11.7M in Q4 2025. 463 funds tracked by Wall St. Rank hold NOV as of Q1 2026.

  • Bridgewater Associates held 182,624 shares of NOV worth $3.44M as of Q1 2026.
  • Bridgewater Associates sold 566,945 NOV shares in Q1 2026, an estimated $10.6M.
  • NOV made up 0.02% of Bridgewater Associates's portfolio in Q1 2026, its #509 holding.
  • Bridgewater Associates first reported a position in NOV in Q4 2013 and has held it in 12 quarters since.
  • Bridgewater Associates's NOV position peaked at $11.7M in Q4 2025.
  • 463 funds tracked by Wall St. Rank held NOV as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.